Psychiatry & Neurology, Clinical Neurophysiology · Lake City, FL
NPI
1396170601
Since 2013
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4241 NW American Ln
Lake City, FL, 32055
Phone (386) 288-5311
Groups this clinician bills Medicare through
Medicare paid, 2024
$849K
61,156 services
Medicare patients, 2024
760
Average age 75
Drug cost, 2024
$2.6M
9,550 prescriptions
Company payments, 2025
$20K
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ernesto Alonso was code J7336 (capsaicin 8% patch, per square centimeter), 26,042 times for 14 patients. In total Ernesto Alonso billed 61,156 services in 68 codes, and Medicare paid $849K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7336 Capsaicin 8% patch, per square centimeter | Office | 26,042 | 14 | $2.60 | $68K |
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 8,000 | 15 | $14.23 | $114K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 5,000 | 11 | $4.98 | $25K |
| 99215 Office E&M - Established | Office | 1,046 | 504 | $130.73 | $137K |
| 99214 Office E&M - Established | Office | 766 | 421 | $95.44 | $73K |
| 97032 PT Treatment | Office | 478 | 24 | $9.64 | $4,608 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 349 | 258 | $12.77 | $4,458 |
| 95885 Electrical Nerve Conductivity | Office | 295 | 173 | $45.97 | $14K |
| 99205 Office E&M - New | Office | 230 | 230 | $164.54 | $38K |
| 95816 Neurologic | Office | 141 | 138 | $290.91 | $41K |
| 95911 Electrical Nerve Conductivity | Office | 106 | 106 | $160.14 | $17K |
| 99483 Office/Outpatient Services | Office | 105 | 103 | $202.99 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 96 | 40 | $57.21 | $5,492 |
| 95909 Electrical Nerve Conductivity | Office | 72 | 72 | $100.21 | $7,215 |
| 92537 Test - Miscellaneous | Office | 65 | 64 | $30.31 | $1,970 |
By year: 2022 $437K for 10,936 services; 2023 $450K for 11,683 services; 2024 $849K for 61,156 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 91 | 89 | $8.40 | $764 |
Medicare prescription drug claims, 2024
In 2024, the drug Ernesto Alonso prescribed most often to Medicare patients was Gabapentin, with 1,560 prescriptions and refills. In total Ernesto Alonso wrote 9,550 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,560 | 2,277 | 414 | $25K |
| Memantine Hcl Generic | 1,429 | 2,433 | 360 | $35K |
| Duloxetine Hcl Generic | 481 | 885 | 137 | $8,716 |
| Topiramate Generic | 416 | 735 | 110 | $4,230 |
| Donepezil Hcl Generic | 344 | 678 | 95 | $2,351 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 329 | 597 | 77 | $5,936 |
| Ubrelvy Ubrogepant | 328 | 392 | 91 | $555K |
| Escitalopram Oxalate Generic | 326 | 590 | 97 | $1,974 |
| Levetiracetam Generic | 291 | 548 | 71 | $6,295 |
| Primidone Generic | 271 | 465 | 62 | $4,391 |
| Pregabalin Generic | 220 | 246 | 51 | $4,009 |
| Meclizine Hcl Generic | 209 | 262 | 90 | $2,430 |
| Quetiapine Fumarate Generic | 197 | 279 | 47 | $3,946 |
| Qulipta Atogepant | 192 | 223 | 40 | $241K |
| Amitriptyline Hcl Generic | 166 | 284 | 41 | $2,166 |
Brand drugs: 1,315 claims; generic drugs: 8,207 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ernesto Alonso $20K ($20K in general payments such as food, travel and fees) from 36 companies. The largest payer was Axsome Therapeutics, Inc. with $9,674.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.